ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Multiple Endocrine Neoplasia Type 1

  • Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
  • FOsfomycin for Male Urinary Tract Infection
  • Open Label, Repeat Dose Study Evaluating YCT-529 in Healthy Males
  • A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women
  • Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial
  • Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
  • 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
  • Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
  • Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment
  • Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group